INOVIO PHARMACEUTICALS, INC. Depreciation
INOVIO PHARMACEUTICALS, INC. (INO) reported Depreciation of $638.88 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-06-30 was $322.03K, a 9.58% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. depreciation for the quarter ending 2026-03-31 was $316.84K, a 14.68% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-12-31 was $340.20K, a 18.38% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. depreciation for the quarter ending 2025-09-30 was $350.20K, a 16.48% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. depreciation for fiscal 2025 was $1.42M, a 19.08% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. depreciation for fiscal 2024 was $1.75M, a 33.17% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. depreciation for fiscal 2023 was $2.62M, a 28.31% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. depreciation for fiscal 2022 was $3.66M, a 20.28% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $322.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $638.88K 10-Q · filed 2026-08-12 | $979.08K derived: sum of 3 quarters · filed 2026-08-12 | $1.33M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $316.84K 10-Q · filed 2026-05-13 | $657.04K derived: sum of 2 quarters · filed 2026-05-13 | $1.01M derived: sum of 3 quarters · filed 2026-05-13 | $1.36M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $340.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $690.39K derived: sum of 2 quarters · filed 2026-03-12 | $1.05M derived: sum of 3 quarters · filed 2026-08-12 | $1.42M 10-K · filed 2026-03-12 |
| 2025-09-30 | $350.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $706.35K derived: sum of 2 quarters · filed 2026-08-12 | $1.08M 10-Q · filed 2025-11-10 | $1.49M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $356.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $727.52K 10-Q · filed 2026-08-12 | $1.14M derived: sum of 3 quarters · filed 2026-08-12 | $1.56M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $371.37K 10-Q · filed 2026-05-13 | $788.19K derived: sum of 2 quarters · filed 2026-05-13 | $1.21M derived: sum of 3 quarters · filed 2026-05-13 | $1.70M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $416.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $836.13K derived: sum of 2 quarters · filed 2026-03-12 | $1.33M derived: sum of 3 quarters · filed 2026-03-12 | $1.75M 10-K · filed 2026-03-12 |
| 2024-09-30 | $419.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $910.85K derived: sum of 2 quarters · filed 2025-11-10 | $1.34M 10-Q · filed 2025-11-10 | $1.91M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $491.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $916.02K 10-Q · filed 2025-08-12 | $1.49M derived: sum of 3 quarters · filed 2025-08-12 | $2.13M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $424.47K 10-Q · filed 2025-05-13 | $994.16K derived: sum of 2 quarters · filed 2025-05-13 | $1.64M derived: sum of 3 quarters · filed 2025-05-13 | $2.34M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $569.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.21M derived: sum of 2 quarters · filed 2025-03-18 | $1.91M derived: sum of 3 quarters · filed 2025-03-18 | $2.62M 10-K · filed 2025-03-18 |
| 2023-09-30 | $641.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.34M derived: sum of 2 quarters · filed 2024-11-14 | $2.05M 10-Q · filed 2024-11-14 | $2.93M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $703.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.41M 10-Q · filed 2024-08-08 | $2.29M derived: sum of 3 quarters · filed 2024-08-08 | $3.20M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $707.38K 10-Q · filed 2024-05-13 | $1.59M derived: sum of 2 quarters · filed 2024-05-13 | $2.49M derived: sum of 3 quarters · filed 2024-05-13 | $3.43M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $880.04K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $1.79M derived: sum of 2 quarters · filed 2024-03-06 | $2.73M derived: sum of 3 quarters · filed 2024-03-06 | $3.66M 10-K · filed 2024-03-06 |
| 2022-09-30 | $906.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.85M derived: sum of 2 quarters · filed 2023-11-09 | $2.78M 10-Q · filed 2023-11-09 | $3.72M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $940.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.87M 10-Q · filed 2023-08-09 | $2.82M derived: sum of 3 quarters · filed 2024-03-06 | $3.55M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | $929.38K 10-Q · filed 2023-05-10 | $1.87M derived: sum of 2 quarters · filed 2024-03-06 | $2.61M derived: sum of 3 quarters · filed 2024-03-06 | $3.31M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $945.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $1.68M derived: sum of 2 quarters · filed 2024-03-06 | $2.38M derived: sum of 3 quarters · filed 2024-03-06 | $3.04M 10-K · filed 2024-03-06 |
| 2021-09-30 | $733.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.43M derived: sum of 2 quarters · filed 2022-11-08 | $2.09M 10-Q · filed 2022-11-08 | $2.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $700.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.36M 10-Q · filed 2022-08-09 | $2.08M derived: sum of 3 quarters · filed 2023-03-01 | $2.79M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $660.70K 10-Q · filed 2022-05-10 | $1.38M derived: sum of 2 quarters · filed 2023-03-01 | $2.09M derived: sum of 3 quarters · filed 2023-03-01 | $2.89M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $715.49K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.43M derived: sum of 2 quarters · filed 2023-03-01 | $2.23M derived: sum of 3 quarters · filed 2023-03-01 | $3.04M 10-K · filed 2023-03-01 |
| 2020-09-30 | $715.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.51M derived: sum of 2 quarters · filed 2021-11-09 | $2.32M 10-Q · filed 2021-11-09 | $3.18M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $798.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.61M 10-Q · filed 2021-08-09 | $2.46M derived: sum of 3 quarters · filed 2022-03-01 | $3.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $809.56K 10-Q · filed 2021-05-10 | $1.66M derived: sum of 2 quarters · filed 2022-03-01 | $2.54M derived: sum of 3 quarters · filed 2022-03-01 | $3.48M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $851.92K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.74M derived: sum of 2 quarters · filed 2022-03-01 | $2.67M derived: sum of 3 quarters · filed 2022-03-01 | $3.60M 10-K · filed 2022-03-01 |
| 2019-09-30 | $883.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.82M derived: sum of 2 quarters · filed 2020-11-09 | $2.75M 10-Q · filed 2020-11-09 | $3.73M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $932.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.86M 10-Q · filed 2020-08-10 | $2.84M derived: sum of 3 quarters · filed 2021-03-01 | $3.77M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $930.91K 10-Q · filed 2020-05-11 | $1.91M derived: sum of 2 quarters · filed 2021-03-01 | $2.84M derived: sum of 3 quarters · filed 2021-03-01 | $3.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $979.09K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.91M derived: sum of 2 quarters · filed 2021-03-01 | $2.85M derived: sum of 3 quarters · filed 2021-03-01 | $3.75M 10-K · filed 2021-03-01 |
| 2018-09-30 | $927.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.87M derived: sum of 2 quarters · filed 2019-11-12 | $2.77M 10-Q · filed 2019-11-12 | $2.84M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $943.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.84M 10-Q · filed 2019-08-08 | $1.91M derived: sum of 3 quarters · filed 2020-03-12 | $2.67M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $897.71K 10-Q · filed 2019-05-09 | $968.09K derived: sum of 2 quarters · filed 2020-03-12 | $1.73M derived: sum of 3 quarters · filed 2020-03-12 | $2.23M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $70.38K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $829.70K derived: sum of 2 quarters · filed 2020-03-12 | $1.33M derived: sum of 3 quarters · filed 2020-03-12 | $1.85M 10-K · filed 2020-03-12 |
| 2017-09-30 | $759.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.26M derived: sum of 2 quarters · filed 2018-11-08 | $1.78M 10-Q · filed 2018-11-08 | $2.20M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $498.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.02M 10-Q · filed 2018-08-07 | $1.44M derived: sum of 3 quarters · filed 2019-03-12 | $1.90M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $522.30K 10-Q · filed 2018-05-09 | $938.10K derived: sum of 2 quarters · filed 2019-03-12 | $1.40M derived: sum of 3 quarters · filed 2019-03-12 | $1.84M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $415.80K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $881.17K derived: sum of 2 quarters · filed 2019-03-12 | $1.32M derived: sum of 3 quarters · filed 2019-03-12 | $1.71M 10-K · filed 2019-03-12 |
| 2016-09-30 | $465.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $904.83K derived: sum of 2 quarters · filed 2017-11-08 | $1.29M 10-Q · filed 2017-11-08 | $1.61M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $439.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $827.33K 10-Q · filed 2017-08-08 | $1.14M derived: sum of 3 quarters · filed 2018-03-14 | $1.42M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $387.87K 10-Q · filed 2017-05-10 | $702.58K derived: sum of 2 quarters · filed 2018-03-14 | $984.91K derived: sum of 3 quarters · filed 2018-03-14 | $1.22M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $314.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $597.04K derived: sum of 2 quarters · filed 2018-03-14 | $834.44K derived: sum of 3 quarters · filed 2018-03-14 | $1.05M 10-K · filed 2018-03-14 |
| 2015-09-30 | $282.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $519.73K derived: sum of 2 quarters · filed 2016-11-09 | $733.72K 10-Q · filed 2016-11-09 | $931.48K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $237.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $451.39K 10-Q · filed 2016-08-08 | $649.14K derived: sum of 3 quarters · filed 2017-03-15 | $833.75K derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $213.99K 10-Q · filed 2016-05-09 | $411.75K derived: sum of 2 quarters · filed 2017-03-15 | $596.35K derived: sum of 3 quarters · filed 2017-03-15 | $725.03K derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $197.75K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $382.36K derived: sum of 2 quarters · filed 2017-03-15 | $511.04K derived: sum of 3 quarters · filed 2017-03-15 | $626.55K 10-K · filed 2017-03-15 |
| 2014-09-30 | $184.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $313.28K derived: sum of 2 quarters · filed 2015-11-09 | $428.80K 10-Q · filed 2015-11-09 | $633.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $128.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $244.19K 10-Q · filed 2015-08-10 | $448.39K derived: sum of 3 quarters · filed 2016-03-14 | $491.93K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $115.52K 10-Q · filed 2015-05-11 | $319.72K derived: sum of 2 quarters · filed 2016-03-14 | $363.25K derived: sum of 3 quarters · filed 2016-03-14 | $404.43K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $204.20K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $247.73K derived: sum of 2 quarters · filed 2016-03-14 | $288.91K derived: sum of 3 quarters · filed 2016-03-14 | $328.75K 10-K · filed 2016-03-14 |
| 2013-09-30 | $43.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $84.71K derived: sum of 2 quarters · filed 2014-11-10 | $124.55K 10-Q · filed 2014-11-10 | $174.18K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $41.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $81.02K 10-Q · filed 2014-08-11 | $130.65K derived: sum of 3 quarters · filed 2015-03-16 | $177.58K derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $39.84K 10-Q · filed 2014-05-12 | $89.47K derived: sum of 2 quarters · filed 2015-03-16 | $136.40K derived: sum of 3 quarters · filed 2015-03-16 | $176.78K derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $49.63K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $96.56K derived: sum of 2 quarters · filed 2015-03-16 | $136.93K derived: sum of 3 quarters · filed 2015-03-16 | $173.75K 10-K · filed 2015-03-16 |
| 2012-09-30 | $46.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $87.31K derived: sum of 2 quarters · filed 2013-11-12 | $124.12K 10-Q · filed 2013-11-12 | $164.41K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $40.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $77.19K 10-Q · filed 2013-08-09 | $117.48K derived: sum of 3 quarters · filed 2014-03-17 | $152.74K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $36.82K 10-Q · filed 2013-05-10 | $77.11K derived: sum of 2 quarters · filed 2014-03-17 | $112.37K derived: sum of 3 quarters · filed 2014-03-17 | $146.68K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $40.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $75.56K derived: sum of 2 quarters · filed 2014-03-17 | $109.86K derived: sum of 3 quarters · filed 2014-03-17 | $142.20K 10-K · filed 2014-03-17 |
| 2011-09-30 | $35.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $69.57K derived: sum of 2 quarters · filed 2012-11-07 | $101.91K 10-Q · filed 2012-11-07 | $153.23K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $34.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $66.64K 10-Q · filed 2012-08-09 | $117.96K derived: sum of 3 quarters · filed 2013-03-18 | $168.57K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $32.34K 10-Q · filed 2012-05-09 | $83.66K derived: sum of 2 quarters · filed 2013-03-18 | $134.26K derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $51.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $101.93K derived: sum of 2 quarters · filed 2013-03-18 | $194.63K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $50.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $143.31K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $92.70K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $237.22K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |